Clinical Trials Sponsored by Takeda

Total 1918 results

Emory University
Takeda Pharmaceuticals North America, Inc.

Recruiting

SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis (SAFE)

Hemophilia A

United States
Takeda
Nimbus Lakshmi, Inc.; Innovaderm Research Inc.

Completed

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

United States, Canada
Julio Barredo, MD
Takeda

Completed

Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL

Refractory Acute Lymphoblastic Leukemia | Relapsed Acute Lymphoblastic Leukemia

United States
Croatian Society for Endocrinology and Diabology
Takeda

Completed

Secondary Care - Continuous Glucose Monitoring (SC-COSMO)

Diabetes Mellitus, Type 2

Croatia
AstraZeneca
Takeda; Covance; Catalent; MMS Holdings, Inc

Completed

Single Ascending Dose Study of MEDI1341 in Healthy Volunteers

Parkinson's Disease

United States
Shire
National Institutes of Health (NIH)

Completed

A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations

Autosomal Dominant Hypocalcemia (ADH)

United States
Shire
Covance; PRA Health Sciences; PharmaNet

Completed

Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy

Mucopolysaccharidosis II | Hunter Syndrome | MPS II

Brazil, Poland, Taiwan
Svendborg Hospital
Takeda; Region of Southern Denmark

Unknown

Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation (INSPIRE-AF)

Atrial Fibrillation

Denmark
Augusta University
Takeda Pharmaceuticals North America, Inc.

Terminated

Efficacy of Lubiprostone in Combination With Standard PEG Preparation

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
University of Aarhus
Takeda; Aarhus University Hospital

Completed

Treatment With PTH After Sternotomy in Cardiac Surgery Patients (PAATH)

Disruption or Dehiscence of Closure of Sternum or Sternotomy

Denmark
Charlottesville Neuroscience
Takeda Pharmaceuticals North America, Inc.

Terminated

A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches

Migraine Headache

United States
University of North Carolina, Chapel Hill
Takeda

Completed

Lubiprostone Effects on Visceral Pain Sensitivity

Irritable Bowel Syndrome

United States
City Hospitals Sunderland NHS Foundation Trust
Takeda

Unknown

Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)

Cerebrovascular Accident | Acute Stroke

United Kingdom
Universiti Putra Malaysia
Takeda Malaysia Sdn. Bhd.

Not yet recruiting

Effectiveness of iDEAL in Improving the Knowledge, Attitude, Practice, Environmental Cleanliness Index and Dengue Index (iDEAL)

Knowledge, Attitudes, Practice

Malaysia
Princess Maxima Center for Pediatric Oncology
Takeda

Recruiting

Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors (Briga-PED)

Anaplastic Large Cell Lymphoma, ALK-Positive | Inflammatory Myofibroblastic Tumor | Other Solid Tumor

France, Netherlands
Takeda
The Organization of Teratology Information Specialists

Recruiting

Post-Marketing Study of Prucalopride Safety In Pregnancy

Chronic Constipation

United States
M.D. Anderson Cancer Center
Takeda; Janssen Pharmaceuticals

Active, not recruiting

Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis

Recurrent Primary Amyloidosis | Refractory Primary Amyloidosis | Newly Diagnosed Primary Amyloidosis

United States
Daniel Dante Yeh
Takeda

Completed

Teduglutide for Enterocutaneous Fistula (ECF)

Postoperative Fistula

United States
Augusta University
Takeda Pharmaceuticals North America, Inc.

Completed

Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation.

Chronic Constipation, Methanogenesis

United States
Vanderbilt University
Takeda

Completed

Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis (EOE)

Suspected Eosinophilic Esophagitis

United States
Boston University
Takeda Pharmaceuticals North America, Inc.

Completed

Use of Expressive Writing in Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome
Tarveda Therapeutics

Recruiting

PEN-866 in Patients With Advanced Solid Malignancies

Neoplasms | Carcinoma | Small Cell Lung Carcinoma | Gastric Cancer | Pancreatic Adenocarcinoma | Solid Tumor | Gastric Adenocarcinoma | Small-cell Lung Cancer | Advanced Cancer | Pancreatic Ductal Adenocarcinoma | Adenocarcinoma of the Pancreas | Endometrial Adenocarcinoma | Squamous Cell Carcinoma of the Penis | Gastroesophageal... and other conditions

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Takeda

Not yet recruiting

Vedolizumab for the Treatment of Collagenous Gastritis

Collagenous Gastritis

United States
Massachusetts General Hospital
Takeda Development Center Americas, Inc.

Recruiting

Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

Crohn Disease

United States
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Takeda

Recruiting

VeDOlizumab PERsistence in IBD Patients After Switching From Intravenous to Subcutaneous Administration : a Real-life Multicenter Study (DOPER) (DOPER)

Inflammatory Bowel Diseases

France
Leiden University Medical Center
Takeda; Netherlands Brain Foundation

Recruiting

Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury (CIAO@TBI)

Traumatic Brain Injury | Trauma, Head

Netherlands
Omar Nadeem, MD
Takeda

Recruiting

Ixazomib + Pomalidomide + Dexamethasone In MM

Multiple Myeloma | Multiple Myeloma in Relapse

United States
Baxalta now part of Shire
Kamada, Ltd.

Terminated

A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD

Graft Versus Host Disease

United States
Matthew Ingham
Takeda; Karyopharm Therapeutics Inc

Withdrawn

Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma

Sarcoma | Ewing Sarcoma | Liposarcoma | Alveolar Soft Part Sarcoma | Malignant Peripheral Nerve Sheath Tumors

United States
Guy's and St Thomas' NHS Foundation Trust
Takeda

Unknown

Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis (FAVOUR)

Ulcerative Colitis

United Kingdom
Massachusetts General Hospital
Takeda Pharmaceuticals North America, Inc.

Completed

Vortioxetine for Menopausal Depression

Depression | Hot Flashes | Sleep | Menopause | Vasomotor Disturbance

United States
University of Michigan
Takeda Pharmaceuticals North America, Inc.

Completed

Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation

Irritable Bowel Syndrome | Constipation

United States
University of Rochester
Takeda Pharmaceuticals North America, Inc.

Terminated

Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD

Gastroesophageal Reflux | GERD

United States
University of Arkansas
Takeda Pharmaceuticals North America, Inc.

Completed

Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis

Constipation | Cystic Fibrosis

United States
Centre Hospitalier Universitaire de Saint Etienne
Takeda France

Not yet recruiting

Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. (VEDIAN)

Crohn's Disease

France
University of Leeds
Takeda; Cancer Research UK; Celgene

Recruiting

Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma (FiTNEss)

Multiple Myeloma

United Kingdom
Joseph Tuscano
Takeda; Celgene

Active, not recruiting

Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma

Myeloma

United States
Centre Hospitalier Universitaire de Saint Etienne
Takeda; Theradiag

Terminated

Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis (PREDIRESPUC)

Ulcerative Colitis

France
Centre Antoine Lacassagne
Millennium: The Takeda Oncology Company

Completed

Hodgkin Lymphoma Treatment With Adcetris and Levact in the Old Patient (HALO)

Safety | Clinical Efficacy

France
University at Buffalo
Takeda Pharmaceuticals North America, Inc.

Completed

Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study

Inflammation

United States
Takeda
Baxalta Innovations GmbH, now part of Shire

Completed

rVWF IN PROPHYLAXIS

Von Willebrand Disease

United States, Spain, Italy, Turkey, Germany, Russian Federation, Netherlands, France, Canada
Korea University Guro Hospital
Takeda Pharmaceuticals International, Inc.

Terminated

Manidipine Versus Amlodipine in Patients With Hypertension

Hypertension

Korea, Republic of
Washington University School of Medicine
Takeda; Queen's University

Completed

Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training (BBS)

Age-related Cognitive Decline

United States
Hellenic Society of Hematology
Takeda; Janssen Pharmaceutica NV

Unknown

Safety and Efficacy of Daratumumab in Combination With Ixazomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (DARIA)

Multiple Myeloma

Greece
Grupo Español de Tumores Huérfanos e Infrecuentes
Takeda

Terminated

Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study. (Greko II)

Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors

Spain
Grupo de Estudos Multicentricos em Onco-Hematologia
Takeda

Unknown

T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients (Tcell-Brazil)

T-cell Lymphoma | NK-Cell Lymphoma | T-cell Lymphoma Adults
Massachusetts General Hospital
Takeda Pharmaceuticals North America, Inc.

Terminated

Clinical Management of Neuropathic Pain With Ramelteon

Neuropathic Pain

United States
Shirley Ryan AbilityLab
Takeda Pharmaceuticals North America, Inc.

Completed

Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation

Constipation

United States
Tufts Medical Center
Takeda Pharmaceuticals North America, Inc.

Completed

Uric Acid and Long-term Outcomes in Chronic Kidney Disease

Chronic Kidney Disease

United States
Tarveda Therapeutics

Completed

PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Carcinoma, Small Cell Lung

United States, United Kingdom

Clinical Trials Sponsored by Takeda

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations